Skip to main content

Table 1 Tumor incidence of SP cells and non-SP cells in vivo

From: Differentiation therapy: sesamin as an effective agent in targeting cancer stem-like side population cells of human gallbladder carcinoma

Cell population

106

105

104

103

102

Tumors

Tumors

Tumors

Tumors

Tumors

SP(SGC-996)

4/4

4/4

3/4

2/4

2/4

Non-SP(SGC-996)

4/4

2/4

1/4

0/4

0/4

SP(GBC-SD)

4/4

4/4

4/4

2/4

2/4

Non-SP(GBC-SD)

4/4

3/4

2/4

0/4

0/4

  1. Increased tumorigenicity of SP cells when injected subcutaneously into nude mice (n = 4 per group). The observational period lasted for six weeks.
Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us